Departamento de Psicobiologia, Universidade Federal de São Paulo, Rua Napoleão de Barros, 925, São Paulo 04024-002, Brazil.
Departamento de Psicobiologia, Universidade Federal de São Paulo, Rua Napoleão de Barros, 925, São Paulo 04024-002, Brazil.
Pharmacol Biochem Behav. 2020 Oct;197:173014. doi: 10.1016/j.pbb.2020.173014. Epub 2020 Aug 12.
Misuse of prescription medications has risen to popularity. Reasons for this practice include the self-medication of sleep and psychiatric disorders and attempts to counteract the dysphoric side effects of stimulant drugs. Clonazepam, a commonly prescribed benzodiazepine, has been increasingly used as a countermeasure to cocaine side-effects, including sleep reduction and anxiety. As both substances may impair sleep and aggravate psychiatric conditions, this study aimed to evaluate the long-term effects of the interaction of clonazepam and cocaine on anxiety-like behavior, and the short-term effects of this drug combination on sleep using male Wistar rats. Animals received saline, cocaine (15 mg/kg), clonazepam (1.25 mg/kg) or both drugs for 16 days. Sleep recording was performed on the first day of treatment to evaluate acute treatment effects. One day after the end of the treatment period, the open field and elevated plus-maze tests were used to assess anxiety-like behavior. Blood samples were collected for analysis of corticosterone levels. Rats receiving both drugs presented an increase in impulsivity when moving between arms in the elevated plus-maze and a reduction in exploratory behavior in the open field test. These findings suggest the presence of a withdrawal behavioral syndrome, which can manifest as a paradoxical increase in exploratory activity after a period without receiving the drug and may indicate the development of dependence. Combined treatment reduced paradoxical sleep time and increased its onset latency. There was no significant difference regarding corticosterone levels across any group. Our results contribute to the understanding of the risks of combining cocaine and clonazepam. Association of these drugs may impair sleep architecture and aggravate the dependence symptoms already seen when these substances are used separately. These findings may be useful in helping to counteract the impairments resulting from the combined use of these 2 substances and to raise awareness of these associated risks.
处方药物的滥用已变得普遍。这种做法的原因包括睡眠和精神障碍的自我治疗,以及试图抵消兴奋剂药物的不愉快副作用。氯硝西泮是一种常用的苯二氮䓬类药物,已越来越多地被用作对抗可卡因副作用的手段,包括减少睡眠和焦虑。由于这两种物质都可能影响睡眠并加重精神状况,因此本研究旨在评估氯硝西泮和可卡因相互作用对焦虑样行为的长期影响,以及这种药物组合对雄性 Wistar 大鼠睡眠的短期影响。动物接受生理盐水、可卡因(15mg/kg)、氯硝西泮(1.25mg/kg)或两种药物治疗 16 天。在治疗的第一天进行睡眠记录,以评估急性治疗效果。在治疗期结束后的一天,进行旷场和高架十字迷宫测试,以评估焦虑样行为。采集血液样本进行皮质酮水平分析。同时接受两种药物的大鼠在高架十字迷宫中移动时手臂之间的冲动性增加,在旷场试验中探索行为减少。这些发现表明存在戒断行为综合征,这种综合征可能表现为在一段时间没有接受药物后,探索性活动出现反常增加,并可能表明依赖的发展。联合治疗减少了反常睡眠时间,并增加了其起始潜伏期。各组之间的皮质酮水平没有显著差异。我们的研究结果有助于了解联合使用可卡因和氯硝西泮的风险。联合使用这些药物可能会破坏睡眠结构,并加重单独使用这些物质时已经出现的依赖症状。这些发现可能有助于对抗这两种物质联合使用所产生的损害,并提高对这些相关风险的认识。